1. HBW Insight
  2. >>Geography
  3. >>Asia

Executive Decisions Roundup

 
• By Malcolm Spicer

Another Coca-Cola exec pops up at NBTY; Hussain helms Glaxo pharma globally; China TCM office veteran returns; T-Bird tabs Huang as COO; and Lee named Calif. DTSC director.

[NBTY Inc.] adds another former Coca-Cola Co. executive to its management as Brian Wynne becomes Americas markets head, working with President and CEO Steve Cahillane, also a Coca-Cola veteran. The vitamin and nutritional supplement manufacturer, marketer and retailer said Dec. 8 Wynne will start in January as president of NBTY Americas and CEO of its U.S. subsidiary, United States Nutrition Inc., with general management responsibility and profit and loss accountability for the Ronkonkoma, N.Y.-based firm’s Wholesale Brands in North and South America. Wynne is a 25-year consumer packaged goods industry veteran who most recently served as Coca-Cola’s senior VP Strategy, Franchise Relations & Transformation for North America. Cahillane left his post as president of Coca-Cola’s Americas division in December 2013 and in September took the helm of Carlyle Group-owned NBTY Also see "Carlyle Group Gives NBTY Helm To Former Coca-Cola Executive Cahillane" - Pink Sheet, 20 August, 2014..

Abbas Hussain, GlaxoSmithKline PLC‘s head of international pharmaceutical business, takes a new role as Global Pharmaceuticals head, in charge of GSK global commercial pharmaceuticals business including the U.S. market....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Asia

Eisai Switches Proton Pump Inhibitor Rabeprazole To OTC In Japan

 
• By David Ridley

Eisai aims to support people in Japan with severe heartburn and discomfort caused by gastric acid related conditions by switching from prescription to OTC status its Pariet-branded proton pump inhibitor.

Thai TikTok Boom Driving Double-Digit Growth In Southeast Asia’s Dietary Supplements Market

 
• By David Ridley

TikTok dietary supplement sales in Thailand grew by an astonishing 635% in 2024, while sales via Vietnam's and Malaysia's traditional e-commerce platforms increased by a still impressive 73% and 83% respectively.

Haleon Completes Deal To Grow Stake In China JV

 
• By Tom Gallen

Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.

APAC Congress: Regulators And Industry Agree ‘Bangkok Joint Initiative on Self-Care’

 
• By David Ridley

Organizations representing APAC health and medicines regulators and the consumer health industry respectively have agreed to “recognize the importance of self-care as a fundamental pillar of health and wellbeing” and “affirm our dedication to advancing self-care as an essential component of Universal Health Coverage.”

More from Geography

EU Parliament Calls For Review Of Wastewater Directive’s Impact On Pharma Sector

 
• By David Ridley

At a recent plenary session the European Parliament adopted a resolution calling on the European Commission to “conduct a new and comprehensive assessment” of the impact of the revised Urban Wastewater Treatment Directive on the pharmaceutical sector.

New Zealand Could Become First Country To Offer Gout Drug Allopurinol OTC

 
• By David Ridley

At the second attempt, New Zealand’s Medicines Classification Committee supported the Rx-to-OTC switch of allopurinol (100mg and 300mg) for people suffering from gout by specifically trained pharmacists.

Supplementation Unlikely To Help With Hereditary Hair Loss, Says German Agency

 
• By David Ridley

Germany’s Federal Institute for Risk Assessment says that there is "no evidence that people with androgenetic alopecia have special dietary needs or a special nutrient requirement.”